JPRN-UMIN000009760招募中1 期
Phase I study of TS-1 and Nedaplatin for previously untreated patients with advanced squamous cell carcionoma of lung - Phase I study of TS-1 and CDGP for sq. cell carcioma of lung
Pulmonary Medicine, NHO Kyoto Medical Center0 个研究点目标入组 15 人开始时间: 2013年1月11日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Interstitial pneumonia or pulmonary fibrosis detectable on chest radiograph. 2.Massive pericardial, pleural effusion or ascites 3.SVC syndrome 4.Symptomatic brain metastasis 5.Active concomitant malignancy 6.Uncontrollable diabetes mellitus or hypertension 7.Liver cirrhosis 8.Myocardial infarction within 6 months, unstable angina, those who received PTCA or CAGB within 6 months, congestive heart failure, uncontrollable arrhythmia 9.Pregnant or lactating women or those who declined contraception. 10.Severe drug allergy 11.Acute inflammatory diseases 12.Refusal against blood transfusion or other supportive therapies 13.Evidence of bleeding diathesis 14.Active infection 15.Those judged to be not suitable by the attending physician 16.Planning of thoracic radiotherapy during the trial.
研究者
相似试验
招募中
2 期
Phase II Study of Nedaplatin+TS-1 for previously untreated patients with squamous cell lung cancerSquamous cell lung cancerJPRN-UMIN000009550Toho university25
未知
不适用
Phase I–II study of TS-1 and Carboplatin in advanced Non Small Lung Cancernon small cell lung cancerJPRN-C000000054Department of Medical Oncology, Kinki University School of Medicine25
尚未招募
1 期
Phase I/II Trial of S-1 and Nedaplatin with concurrent radiotherapy in locally advanced mesopharynx, hypopharynx cancerMesopharyngeal cancer Hypopharyngeal CancerJPRN-UMIN000003889Kitasato University School of Medicine43
招募中
1 期
Phase I/II trial of Nedaplatin/S-1 combination followed by maintenance S-1 therapy in advanced Squamous Cell Lung CancerJPRN-UMIN000009399Department of Medical Oncology, Kinki University Faculty of Medicine25
已完成
2 期
Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites (KMOG 0607)Carcinoma of Unknown Primary SitesJPRN-UMIN000001364Kyushu Medical Oncology Group38